Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,878Revenue (TTM) $M4,464Net Margin (%)13.5Altman Z-Score2.5
Enterprise Value $M21,228EPS (TTM) $0.9Operating Margin %23.2Piotroski F-Score4
P/E(ttm)30.5Beneish M-Score-2.3Pre-tax Margin (%)17.6Higher ROA y-yN
Price/Book4.510-y EBITDA Growth Rate %22.4Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %20.9Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow64.4y-y EBITDA Growth Rate %3.3ROA % (ttm)5.7Higher Current Ratio y-yN
Dividend Yield %1.6PEG1.5ROE % (ttm)15.8Less Shares Outstanding y-yN
Payout Ratio %41.0Shares Outstanding M683ROIC % (ttm)11.4Gross Margin Increase y-yN

Gurus Latest Trades with GRFS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GRFS is held by these investors:



GRFS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about GRFS:

    News about GRFS:

    Articles On GuruFocus.com
    Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Exten Apr 24 2017 
    Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Apr 17 2017 
    Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 Apr 04 2017 
    John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
    John Paulson Raises Stake in Valeant, Teva Pharmaceutical Mar 18 2016 
    Gold-Focused Guru John Paulson Reports First Quarter Holdings May 22 2014 
    Is Grifols Being Overlooked? Mar 19 2014 
    John Paulson's Top Five Holdings Nov 20 2013 
    John Paulson's Top Five Holdings Sep 12 2013 
    Baron Funds Comments on Grifols SA Aug 30 2012 

    More From Other Websites
    Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View Apr 27 2017
    Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View Apr 27 2017
    Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year... Apr 24 2017
    Nivalis' (NVLS) Shares Down After Merger Deal with Alpine Apr 20 2017
    GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1% Apr 20 2017
    How to Uncover Institutional Buying Apr 19 2017
    Can young blood pump new life into treatments for diseases of aging? Apr 19 2017
    Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of... Apr 17 2017
    Amgen Files for Xgeva Label Expansion, To Include Myeloma Apr 05 2017
    Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk Apr 04 2017
    Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 Apr 04 2017
    New Breakout Stocks Zacks Rank #1 (Strong Buy) Apr 01 2017
    AbbVie's (ABBV) Humira Drug Label Update Approved by FDA Mar 31 2017
    New Strong Buy Stocks for March 30th Mar 30 2017
    Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2% Mar 28 2017
    Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod Mar 21 2017
    AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal Mar 20 2017
    Is Grifols a Great Stock for Value Investors? Mar 17 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)